Z-0915-2023 Class II Ongoing

Recalled by Medtronic Neuromodulation — Minneapolis, MN

FDA device recall Z-0915-2023 was initiated by Medtronic Neuromodulation on Dec 3, 2022 and is designated Class II. Reason for recall: Software anomalies, CP App messages: "Too Many Device Found", "Unexpected Device Error Code 1502", and "System Update Needed, Service Code 303" The recall status is ongoing. Affected quantity: 22 units.

Recall Details

Product Type
Devices
Report Date
Jan 18, 2023
Initiation Date
Dec 3, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
22 units

Product Description

Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for pain therapy, Model Number CT900E

Reason for Recall

Software anomalies, CP App messages: "Too Many Device Found", "Unexpected Device Error Code 1502", and "System Update Needed, Service Code 303"

Distribution Pattern

Worldwide distribution.

Code Information

GTIN 00763000447090: Serial/Lot Numbers: NPL3022869, NPL3022873, NPL3022049, NPL3022050, NPL3022795, NPL3022817, NPL3022190, NPL3022191, NPL3022052, NPL3022187, NPL3022193, NPL3022194, NPL3022195, NPL3022212, NPL3022213, NPL3022289, NPL3021964, NPL3022043, NPL3022044, NPL3022034, NPL3021984, NPL3021990

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0915-2023
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 24, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.